Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02799602 |
|---|---|
| Brief Title: | ODM-201 in Addition to Standard ADT and Docetaxel in Metastatic Castration Sensitive Prostate Cancer (ARASENS) |
| First Submitted : | June 6, 2016 |
| First Submitted that Met QC Criteria : | June 10, 2016 |
| First Posted : | June 15, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 28, 2022 |
| Last Update Posted : | September 29, 2022 |